我们旨在通过收集不同患者资料，从而评价微血管密度计数(如血管形成的测量)是否可在非小细胞肺癌中作为一种预后因子。
We aimed to collect individual patient data to assess microvessel-density counts (ie, a measure of angiogenesis) as a prognostic factor in non-small-cell lung carcinoma.
分别以微机图像分析系统和人工计数对微血管内皮细胞面积(MEA)和微血管密度(MVD)进行定量分析。
Microvessel endothelial area (mea) and microvessel density (MVD) were determined by means of computer aided image analysis system (CIAS) and manual count.
对手术标本进行抗CD34因子及抗VEGF因子免疫组化染色，测量肿块微血管密度计数及血管内皮生长因子（VEGF）阳性表达率，与超声彩色像素密度值相比较。
The microvessel density and vascular endothelial growth factor was measured in surgical specimen after immunohistochemical staining using anti-factor CD34, VEGF and compared to color pixel density.
MVD计数显示卵巢恶性肿瘤的微血管密度大于良性肿瘤（P<0.05）；
The MVD of the malignant tumors was significantly greater than that of the benign rumors (P<0.05).
MVD计数显示卵巢恶性肿瘤的微血管密度大于良性肿瘤（P<0.05）；
The MVD of the malignant tumors was significantly greater than that of the benign rumors (P<0.05).
应用推荐